Lessening Health Inequalities in Type 2 Diabetes Through Innovative Drug Repurposing
-
UK
-
University of Dundee
-
On Campus (Full Time)
3 years-
PhD Studentship
-
Unspecified
On Campus (Full Time) Position Details (PhD Program)
In this Lessening Health Inequalities in Type 2 Diabetes Through Innovative Drug Repurposing project at University of Dundee, the student will study the mitochondrial impact of PK activators on wild-type L6 cell and those lacking PKM2.
In this Lessening Health Inequalities in Type 2 Diabetes Through Innovative Drug Repurposing Lessening Health Inequalities in Type 2 Diabetes Through Innovative Drug Repurposing project at University of Dundee University of Dundee , the student will use Seahorse methodology to investigate pyruvate kinase (PK) M2 activators as a potential novel therapy for direct alleviation of muscle cell insulin resistance, something that no clinically-approved drug currently achieves.
Context
Most older type 2 diabetes (T2D) drugs were developed through pre-clinical studies and then trials that model T2D as it is experienced by older white people. These drugs tend to be less efficacious in currently difficult-to-treat T2D, such as can often be experienced for example, by younger people and/or ethnic minorities. Recently, relative lack of muscle mass, by accelerating onset and severity of insulin resistance, has been highlighted as a new additional target that should be exploited to address currently difficult-to-treat T2D.
The student will study
- material from knockout and wild-type animals.